ICRA Limited to meet Systematix Shares on May 27, 2026

0 min read     Updated on 25 May 2026, 08:29 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

ICRA Limited has scheduled a one-on-one investor meeting with Systematix Shares and Stocks (India) Ltd on May 27, 2026, in Mumbai. The company confirmed that discussions will be based on publicly available information and no unpublished price sensitive information will be shared.

powered bylight_fuzz_icon
41266752

*this image is generated using AI for illustrative purposes only.

ICRA Limited has scheduled a one-on-one investor meeting with Systematix Shares and Stocks (India) Ltd on May 27, 2026. The meeting is set to take place in-person in Mumbai. This interaction is part of the company’s ongoing engagement with analysts and institutional investors.

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that the schedule is subject to change due to exigencies on the part of the company, investor, or analyst.

ICRA Limited emphasized that discussions during the meeting will be based on publicly available documents. The company stated that no unpublished price sensitive information will be shared or discussed during the call or meeting.

Meeting Schedule

Date Investors/Analysts/Events Mode/Location Type of meeting
May 27, 2026 Systematix Shares and Stocks (India) Ltd In-person; Mumbai One-to-One

Historical Stock Returns for ICRA

1 Day5 Days1 Month6 Months1 Year5 Years
+0.88%+0.71%+0.08%-10.85%-14.42%+72.21%

What key topics are analysts likely to focus on during the meeting given ICRA's recent performance?

How might this engagement influence investor sentiment ahead of ICRA's next earnings report?

Could this meeting signal potential strategic shifts or new business developments for ICRA?

ICRA FY26 Net Profit Rises 6.6% to ₹1,825 Cr

2 min read     Updated on 23 May 2026, 12:07 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

ICRA Limited reported a 6.6% increase in consolidated net profit to ₹1,825.32 crore for FY26, while revenue from operations grew to ₹5,995.10 crore. For Q4 FY26, net profit was ₹526.91 crore on revenue of ₹1,748.52 crore. The board recommended a final dividend of ₹105 per share, including a special dividend of ₹35, with a record date of July 23, 2026.

powered bylight_fuzz_icon
40917478

*this image is generated using AI for illustrative purposes only.

ICRA Limited has announced its audited financial results for the fourth quarter and financial year ended March 31, 2026. The company reported a consolidated net profit of ₹1,825.32 crore for FY26, marking a 6.6% rise from ₹1,712.04 crore in the previous fiscal year. Revenue from operations for the year stood at ₹5,995.10 crore, compared to ₹4,980.21 crore in FY25.

Financial Performance

For the quarter ended March 31, 2026, the company posted a consolidated net profit of ₹526.91 crore, compared to ₹559.90 crore in the corresponding quarter of the previous year. Revenue from operations for the quarter increased to ₹1,748.52 crore from ₹1,362.13 crore in Q4 FY25. Total income for the quarter rose to ₹1,890.33 crore.

The following table summarises key consolidated financial metrics for the full year and the latest quarter:

Metric FY26 FY25 Change
Revenue from Operations ₹5,995.10 crore ₹4,980.21 crore Increase
Net Profit ₹1,825.32 crore ₹1,712.04 crore +6.6%
Total Income ₹6,745.32 crore ₹5,754.33 crore Increase
Basic EPS ₹188.63 ₹176.73 Increase

Segmental Performance

ICRA delivered strong revenue growth across businesses, driven by continued momentum in Ratings and robust growth in Research & Analytics (R&A), led primarily by the Fintellix acquisition. For FY26, the Ratings & ancillary services segment reported revenue of ₹336.5 crore, while the Research & Analytics segment recorded revenue of ₹265.8 crore. Segment results before Labour Codes impact stood at ₹126.4 crore for Ratings and ₹64.5 crore for Research & Analytics.

Q4 EBITDA and Margin

On an operational profitability basis, ICRA's Q4 EBITDA stood at ₹695 million, up from ₹592 million in the same quarter of the previous year. However, the EBITDA margin contracted to 39.78% in Q4 from 43.43% in the corresponding period of the prior year, indicating that revenue growth outpaced operating profit expansion during the quarter.

Operational Highlights

The company's earnings per share (EPS) on a consolidated basis for FY26 was ₹188.63, up from ₹176.73 in the previous year. For the quarter ended March 31, 2026, the basic EPS was recorded at ₹54.50. The company's total comprehensive income for the year stood at ₹1,824.51 crore.

The board of directors has recommended a final dividend of ₹105 per equity share for the financial year ended March 31, 2026. This includes a special dividend of ₹35 per share to commemorate the company's 35th year of operations. The total dividend payout amounts to ₹101.34 crore, including the special dividend component of ₹33.78 crore. The record date for the dividend payment has been fixed as July 23, 2026.

Corporate Actions

The Thirty-Fifth Annual General Meeting (AGM) of the company is scheduled to be held on July 30, 2026, via Video Conferencing (VC) or Other Audio Visual Means (OAVM). The record date for determining eligibility for the AGM and the dividend payment is July 23, 2026. The dividend will be paid on or before August 21, 2026, subject to approval by shareholders at the AGM.

Historical Stock Returns for ICRA

1 Day5 Days1 Month6 Months1 Year5 Years
+0.88%+0.71%+0.08%-10.85%-14.42%+72.21%

How will the Fintellix acquisition continue to shape ICRA's Research & Analytics segment revenue trajectory in FY27, and are further acquisitions planned to strengthen this business line?

Given the EBITDA margin contraction to 39.78% in Q4 FY26, what cost optimization measures is ICRA likely to implement to improve operational efficiency in the coming quarters?

With India's credit rating market expected to grow amid increased corporate borrowing and infrastructure spending, how might ICRA's Ratings segment capture a larger market share relative to competitors like CRISIL and CARE Ratings?

More News on ICRA

1 Year Returns:-14.42%